fibroblasts to create stem-cell-like regenerative solutions for autoimmune diseases, neurodegenerative disorders, and osteoarthritis.

With a global approach, Celljevity integrates cutting-edge Western science with holistic medical insights, conducting fast-track clinical trials in Kazakhstan while preparing for market expansion in the U.S., Europe, and Asia. Their product pipeline includes VitaCell™ (autoimmune treatment), ImmuneSync™ (precision autoimmune diagnostics), ReGenova™ (osteoarthritis therapy), and NeuroRevive™ (neurodegenerative disease treatment). Guided by a leadership team of biotech entrepreneurs, venture capital experts, and world-renowned scientists—including UCLA researchers and Nobel Laureate advisors—Celljevity is at the forefront of longevity science. Beyond innovation, their mission is deeply humanitarian, aiming to make regenerative therapies affordable and accessible worldwide.